Entries tagged "Big Pharma"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Big Pharma."

10 result(s) displayed (1 - 10 of 10)

Putting a price on promise

The complex world of pharmaceutical collaborations and partnerships is the most active and evolving area of life sciences dealmaking -- and the least transparent. Continue reading

Posted on January 4, 2013 3:23 PM

Affordable Care Act is here to stay

The president's victory means the ACA is here to stay, so drug companies and device makers are taking stock in what, exactly, that means. Continue reading

Posted on November 12, 2012 8:26 AM

Idenix slapped with second FDA hold

The ripple effects of Bristol-Myers' Inhibitex problems continue Continue reading

Posted on August 27, 2012 2:26 PM

Sarepta shares surge on drug breakthrough

After the company releases positive Phase 2b data on eteplirsen, a compound that treats Duchenne muscular dystrophy, talk turns to the possibility of a takeover Continue reading

Posted on July 25, 2012 9:22 AM

A few thoughts on Bell Labs

Bell Labs harkens back to an age that viewed the largest corporations as not only the vanguard of modernity, but the most rational, most innovative, organization in history. Continue reading

Posted on February 28, 2012 12:16 PM

Teva buys out Japanese JV partner

The generic drugmaker will pay Kowa $150 million as part of a plan to establish itself as a market leader in Japan. Continue reading

Posted on September 26, 2011 3:13 PM

Another shift in cancer research

Is cancer a homogenous disease that can eventually be 'cured' by investigation of fundamental cellular malfunctions, or is it a heterogeneous jumble of tumors and mutations? Continue reading

Posted on June 6, 2011 3:51 PM

Why drug R&D is so difficult

Megan McArdle at The Atlantic tackles pharmaceutical research and asks why developing new drugs are so difficult. Her answer is the obvious one: because it's really difficult. Continue reading

Posted on May 25, 2011 3:30 PM

Little pharma blues

As the economy foundered, drug industry insiders looked forward to an M&A frenzy. But with a few exceptions, deals occurred only at the top of the food chain. Continue reading

Posted on March 20, 2009 1:48 PM

Movable Type search results powered by Fast Search